Similarly, the influence of antigenic heterogeneity has been evident in other hematological malignancies, particularly highlighted by the absence of CD19 expression in Hodgkin Lymphoma (HL) and T-cell malignancies (11). This evidence concerns the gene CD19 and Hodgkins lymphoma.